A Phase II Study of Pomalidomide in Myelofibrosis With Myeloid Metaplasia
Status:
Completed
Trial end date:
2013-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety of and to select a treatment regimen of
pomalidomide (CC-4047) either as single-agent or in combination with prednisone to study
further in patients with myelofibrosis with myeloid metaplasia (MMM).